Global Oral Cancer Treatment Market to Reach US$ 2.5 Billion by 2028, Fostered by Rising Smoking Habits and Consumption of Tobacco Products

April 13, 2023 | Healthcare

According to the latest report by IMARC Group, titled "Oral Cancer Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028," the global oral cancer treatment market size reached US$ 1.8 Billion in 2022. Oral cancer treatment refers to the diagnosis and treatment of cancer that occurs in the tissues of lips, gums, inner lining of the cheeks, tongue, and the upper and lower floor of the mouth cavity. It comprises a wide variety of methods, such as surgery, chemotherapy, and radiation, wherein mostly X-rays are used to kill malignant cells forming tumors or lumps. It relies on various imaging tests, such as X-ray images, computerized tomography (CT) scans, magnetic resonance imaging (MRI), and positron emission tomography (PET) scans. Oral cancer treatment is carried out by an oncologist who initially examines the affected area to spot any abnormalities, carries out testing procedures or biopsy to detect cancer cells, and suggests the appropriate treatment to prevent the spread of cancer. As it is effective in treating cancer cells in salivary glands, tonsils, pharynx, and gums, the demand for oral cancer treatment is rising across the globe.

Global Oral Cancer Treatment Market Trends:

At present, the increasing occurrence of oral cancer among the masses due to excessive smoking of cigars, cigarettes, and pipes and chewing of tobacco represents one of the primary factors influencing the market positively. Besides this, the rising adoption of smoking habits among youngsters influenced by peer pressure is propelling the growth of the market. In addition, governing agencies of various countries are investing in the improvement of healthcare infrastructure and increasing the construction of hospitals, nursing homes, and clinics to provide quality healthcare services to patients. Apart from this, the growing awareness about the early detection and treatment of oral cancer is offering a favorable market outlook. Additionally, the rising innovation and research activities by key players to develop effective and accurate treatment methods and immunotherapy drugs for oral cancer are supporting the growth of the market. On account of the aforementioned factors, the market is anticipated to reach a value of US$ 2.5 Billion by 2028, exhibiting a CAGR of 5.50% during 2023-2028.

Market Summary:

On the basis of the type, the market has been segmented into oral squamous cell carcinoma, oral verrucous carcinoma, mucoepidermoid carcinoma, and oral cavity lymphomas. Oral squamous cell carcinoma currently represents the largest segment.
Based on the treatment type, the market has been segregated into chemotherapy, radiation therapy, targeted therapy, surgery, and others. At present, radiation therapy holds the biggest share in the market.
On the basis of the age group, the market has been classified into 30-49, 50-69, and above 70. Presently, 50-69 exhibits a clear dominance in the market.
Based on the end user, the market has been categorized into hospital, home care, specialty clinics, and others. Presently, hospital dominates the market.
Region-wise, the market has been divided into North America (the United States and Canada); Europe (the United Kingdom, Germany, France, Italy, Spain, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. Amongst these North America (the United States and Canada) enjoys the leading position in the market.
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market. Some of the key players include Bristol-Myers Squibb Company and Merck & Co. Inc.

Report Scope:

Report Features	Details
Base Year of the Analysis	2022
Historical Period	2017-2022
Forecast Period	2023-2028
Units	US$ Billion
Types Covered	Oral Squamous Cell Carcinoma, Oral Verrucous Carcinoma, Mucoepidermoid Carcinoma, Oral Cavity Lymphomas
Treatment Types Covered	Chemotherapy, Radiation Therapy, Targeted Therapy, Surgery, Others
Age Groups Covered	30-49, 50-69, Above 70
End-Users Covered	Hospital, Home Care, Specialty Clinics, Others
Regions Covered	Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered	United States, Canada, Germany, France, United Kingdom, Italy, Spain, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered	Bristol-Myers Squibb Company, Merck & Co. Inc., etc.
Customization Scope	10% Free Customization
Report Price and Purchase Option	Single User License: US$ 2499 Five User License: US$ 3499 Corporate License: US$ 4499
Post-Sale Analyst Support	10-12 Weeks
Delivery Format	PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group
134 N 4th St.
Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

Need more help?

Speak to our experienced analysts for insights on the current market scenarios.
Include additional segments and countries to customize the report as per your requirement.
Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
For further assistance, please connect with our analysts.

Global Oral Cancer Treatment Market to Reach US$ 2.5 Billion by 2028, Fostered by Rising Smoking Habits and Consumption of Tobacco Products

Purchase options Year End sale

Single User License ~~$2499~~ $2249
Five User License ~~$3499~~ $2974
Corporate License ~~$4499~~ $3599

Inquire Before Buying

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Speak to an Analyst

Request Brochure

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-713-2163

Email: sales@imarcgroup.com

Client Testimonials

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.